Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1804181Erstellt: 25. Oktober 2026

(4R)-4-ethyl-1,3-oxazolidin-2-one → (R)-4-ethyl-3-[5-(4-p-tolyloxypiperidine-1-carbonyl)pyridin-2-yl]oxazolidin-2-one

https://huagongshe.com/reaction/1804181

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt(4R)-4-ethyl-1,3-oxazolidin-2-oneHCID 641503—
Edukt(6-Bromopyridin-3-yl)[4-(p-tolyloxy)piperidin-1-yl]methanoneHCID 58484591—
Produkt(R)-4-ethyl-3-[5-(4-p-tolyloxypiperidine-1-carbonyl)pyridin-2-yl]oxazolidin-2-oneHCID 4619017620%

Reaktionsschritte

By reaction and treatment in the same manner as in Example 40 and using (6-bromopyridin-3-yl)(4-p-tolyloxypiperidin-1-yl)methanone (1.2 g) described in Preparation Example 28 and (R)-4-ethyloxazolidin-2-one (525 mg) described in Preparation Example 26, the title compound (262 mg) was obtained.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08354401B2
Quelldatensatzuspto-grants-2013_01
ORD IDord-6c397034ad944e5988bf103c627dc2b2
Quellennotizuspto-grants-2013_01